Memphasys Ltd

MEM

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    28

Stocks News & Analysis

stocks

The trillion-dollar club: Are these mega-sized stocks still buys?

The biggest stocks got bigger this year, breaking multi-trillion-dollar milestones.
stocks

New pricing model for embattled ASX tech leader

Investor day shows off potentially disruptive pricing model.
stocks

Chart of the Week: We see opportunity in Mineral Resources despite debt concerns

Shares trade at a discount despite attractive longer-term outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,926.1019.300.22%
CAC 408,124.192.160.03%
DAX 4024,083.08201.050.84%
Dow JONES (US)47,931.8580.910.17%
FTSE 1009,693.7917.08-0.18%
HKSE26,085.08149.180.58%
NASDAQ23,594.9189.770.38%
Nikkei 22550,491.87536.55-1.05%
NZX 50 Index13,483.9931.63-0.23%
S&P 5006,874.6417.520.26%
S&P/ASX 2008,634.6020.500.24%
SSE Composite Index3,902.8127.010.70%

Market Movers